财经快讯|安图生物：受新冠检测类产品需求下降影响，上半年归母净利润同比微涨2.32%
安图生物8月17日公告，公司上半年实现营业收入21.08亿元，同比上涨1.82%；归母净利润5.46亿元，同比上涨2.32%；基本每股收益0.94元。
业绩变动主要是一方面本期公司受新冠检测类产品需求下降影响，同期有新冠检测类产品收入，本期该类收入销售金额少；另一方面新冠检测类产品受市场需求影响，计提存货跌价准备。上半年剔除新冠检测类相关收入影响后，营业收入与上年同期相比增长约23%，主要是公司自产品收入增加。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Related News
